7-fluoro-1,3,4,5-tetrahydro-1-benzazepin-2-one is primarily utilized in pharmaceutical research and development. It serves as a key intermediate in the synthesis of various bioactive compounds, particularly those targeting neurological disorders. Its structure is often explored for potential applications in the development of drugs that modulate neurotransmitter systems, such as those involved in anxiety, depression, and epilepsy. Additionally, it is investigated for its role in creating novel therapeutic agents with improved efficacy and reduced side effects. Researchers also study its derivatives for potential use in treating chronic pain and neurodegenerative diseases. Its versatility makes it a valuable compound in medicinal chemistry for designing and optimizing new drug candidates.